What CERo Therapeutics Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Atwood Brian G | Director | Mar 31 | Exercise / conversion · M | +294,460 | $0.00 | +$29.4 | 490,534 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 13 | Open-market sale · S | −2,998,908 | $0.06 | −$180K | 13,005,169 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 12 | Open-market sale · S | −1,614,541 | $0.07 | −$113K | 16,004,077 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 11 | Open-market sale · S | −1,343,801 | $0.08 | −$108K | 17,618,618 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 10 | Open-market sale · S | −1,570,947 | $0.09 | −$141K | 18,962,419 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 09 | Open-market sale · S | −850,543 | $0.11 | −$93.6K | 20,533,366 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Dec 06 | Open-market sale · S | −1,236,874 | $0.12 | −$148K | 21,383,909 |
| Yk Bioventures Opportunities Gp I, Llc | 10% owner | Oct 10 | Open-market sale · S | −3,250,000 | $0.10 | −$325K | 22,620,783 |
| Laporte Kathleen | Director | Sep 25 | Exercise / conversion · M | +965,997 | — | — | 965,997 |
| Sloan Stuart M | 10% owner | Sep 25 | Open-market sale · S | −532,486 | $0.10 | −$55.5K | 21,067,956 |
| Atwood Brian G | Director | Sep 25 | Exercise / conversion · M | +19,358,578 | — | — | 19,607,313 |
| Ehrlich Christopher B | Interim Chairman and CEO | Sep 25 | Exercise / conversion · M | +5,312,983 | — | — | 5,791,808 |
| Kosacz Barbara | Director | Feb 14 | Other Transaction · J | +5,828 | — | — | 5,828 |
| Phoenix Biotech SPONSOR, Llc | 10% owner | Feb 14 | Other Transaction · J | −4,171,246 | — | — | 1,000,000 |
| Phoenix Biotech SPONSOR, Llc | 10% owner | Feb 14 | Other Transaction · J | −1,125,000 | — | — | 4,171,246 |
| Fisher Douglas | President | Feb 14 | Other Transaction · J | +43,300 | — | — | 43,300 |
| Loewy Caroline M | Director | Feb 14 | Other Transaction · J | +5,828 | — | — | 5,828 |
| Geffken Daniel E | Chief Financial Officer | Feb 14 | Other Transaction · J | +10,002 | — | — | 10,002 |
| Atwood Brian G | Chief Executive Officer | Feb 14 | Other Transaction · J | +148,208 | — | — | 248,735 |
| Atwood Brian G | Chief Executive Officer | Feb 14 | Other Transaction · J | +100,527 | — | — | 100,527 |
Loading...